0 Comentários
0 Compartilhamentos
592 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Chemiluminescence Analyzer (CLA) Market: Clinical Diagnostics, Immunoassay Systems, and High-Throughput Laboratory Testing"What’s Fueling Executive Summary Chemiluminescence Analyzer (CLA) Market Size and Share Growth The global chemiluminescence analyzer (CLA) market size was valued at USD 7.24 billion in 2024 and is expected to reach USD 11.98 billion by 2032, at a CAGR of 6.50% during the forecast period To stand apart from the competition, a careful idea about the...0 Comentários 0 Compartilhamentos 943 Visualizações 0 Anterior
-
Clinical Next-Generation Sequencing Testing Market Advances Precision Medicine ApplicationsExecutive Summary Clinical Next-Generation Sequencing (NSG) Testing Market Size and Share Forecast The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period By considering a definite base year...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Europe Mycoplasma Testing in Clinical Market Trends, Growth, and Future Outlook"Executive Summary Europe Mycoplasma Testing in Clinical Market Research: Share and Size Intelligence Data Bridge Market Research analyses that the mycoplasma testing in clinical market which was USD 52.52 million in 2022, is expected to reach USD 106.75 million by 2030, at a CAGR of 8.2% during the forecast period 2023 to 2030. This Europe Mycoplasma Testing in Clinical Market research report...0 Comentários 0 Compartilhamentos 594 Visualizações 0 Anterior
-
Global Clinical NGS Testing Market Surges with Precision Medicine Growth and Faster Genetic DiagnosticsDetailed Analysis of Executive Summary Clinical Next-Generation Sequencing (NSG) Testing Market Size and Share The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period With this Clinical...0 Comentários 0 Compartilhamentos 872 Visualizações 0 Anterior
-
How Is NGS Testing Transforming the Clinical Diagnostics Market?"Comprehensive Outlook on Executive Summary Clinical Next-Generation Sequencing (NSG) Testing Market Size and Share The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period This competitive era...0 Comentários 0 Compartilhamentos 927 Visualizações 0 Anterior
-
Is the Global Clinical NGS Testing Market Transforming Precision Medicine?Executive Summary Clinical Next-Generation Sequencing (NSG) Testing Market: Growth Trends and Share Breakdown CAGR Value The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period This Clinical...0 Comentários 0 Compartilhamentos 175 Visualizações 0 Anterior
-
Middle East & Africa Mycoplasma Testing In Clinical Market Future, Size, and Analysis"Regional Overview of Executive Summary Middle East & Africa Mycoplasma Testing In Clinical Market by Size and Share Data Bridge Market Research analyses a growth rate in the mycoplasma testing in clinical market in the forecast period 2023-2030. The expected CAGR of mycoplasma testing in clinical market is tend to be around 5.10% in the mentioned forecast period. The market is valued...0 Comentários 0 Compartilhamentos 588 Visualizações 0 Anterior
-
Middle East and Africa Mass Spectrometry Market: Clinical Lab Modernization, Pharmaceutical R&D Investments, and Food Safety Testing Trends"Comprehensive Outlook on Executive Summary Middle East and Africa Mass Spectrometry Market Size and Share The Middle East and Africa mass spectrometry market size was valued at USD 2.81 billion in 2024 and is expected to reach USD 5.32 billion by 2032, at a CAGR of 8.30% during the forecast period The Middle East and Africa Mass Spectrometry report includes a...0 Comentários 0 Compartilhamentos 932 Visualizações 0 Anterior
-
North America Mycoplasma Testing in Clinical Market Growth, Trends, and Competitive Analysis"Detailed Analysis of Executive Summary North America Mycoplasma Testing in Clinical Market Size and Share Data Bridge Market Research analyses a growth rate in the mycoplasma testing in clinical market in the forecast period 2023-2030. The expected CAGR of mycoplasma testing in clinical market is tend to be around 7.30% in the mentioned forecast period. The market is valued at USD 136.90...0 Comentários 0 Compartilhamentos 581 Visualizações 0 Anterior
-
Professional Diagnostics Market: High-Accuracy Clinical Testing Platforms Accelerating Early Disease Detection"Executive Summary Professional Diagnostics Market Size and Share Analysis Report CAGR Value Professional diagnostics market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to grow at a CAGR of 6.70% in the above-mentioned forecast period. Professional Diagnostics Market report objective analysis is employed to...0 Comentários 0 Compartilhamentos 783 Visualizações 0 Anterior
-
Radio Immunoassay (RIA) Reagents and Devices Market: Diagnostic Technology, Clinical Laboratory Applications, and Nuclear Medicine Testing"Executive Summary Radio Immunoassay (RIA) Reagents and Devices Market: Share, Size & Strategic Insights The global Radio Immunoassay (RIA) reagents and devices market size was valued at USD 28.05 billion in 2024 and is expected to reach USD 48.19 billion by 2032, at a CAGR of 7.00% during the forecast period Radio Immunoassay (RIA) Reagents and Devices Market...0 Comentários 0 Compartilhamentos 927 Visualizações 0 Anterior
-
Carcinoembryonic Antigen Market to Reach USD 3.16 Billion by 2033, Growing at 5.06% CAGRMarket Overview The global carcinoembryonic antigen market size was valued at USD 2.03 billion in 2024 And is projected to reach from USD 2.13 billion in 2025 to USD 3.16 billion by 2033, growing at a CAGR of 5.06% during the forecast period (2024–2032). The global Carcinoembryonic Antigen market continues to evolve rapidly, driven...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
Global Cancer Diagnostics Market to Reach USD 178.26 Billion by 2033, Driven by Rising Screening DemandMarket Overview The global cancer diagnostics market size was valued at USD 106.32 billion in 2024 and is projected to reach from USD 112.60 billion in 2025 to USD 178.26 billion by 2033, growing at a CAGR of 5.91% during the forecast period (2025-2033). The global Cancer Diagnostics market continues to evolve rapidly, driven by shifting consumer trends,...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
How Is CTC-Based Liquid Biopsy Advancing Cancer Diagnostics in Europe?"Executive Summary Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Share Forecast Data Bridge Market Research analyses that the market is growing with a CAGR of 24.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,891.60 million by 2029 from USD 351.05 million in 2021. By considering a definite base year and historic year, calculations in the...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
How Is CTC-Based Liquid Biopsy Advancing Cancer Diagnostics in Europe?"Executive Summary Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Share Forecast Data Bridge Market Research analyses that the market is growing with a CAGR of 24.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,891.60 million by 2029 from USD 351.05 million in 2021. By considering a definite base year and historic year, calculations...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
In Vitro Diagnostics Market Expands Rapidly with Rising Demand for Early Disease DetectionIn-Depth Study on Executive Summary In Vitro Diagnostics (IVD) Market Size and Share The global In Vitro Diagnostics (IVD) market size was valued at USD 135.73 billion in 2025 and is expected to reach USD 200.54 billion by 2033, at a CAGR of 5.00% during the forecast period All statistical and numerical data is interpreted with the use of...0 Comentários 0 Compartilhamentos 550 Visualizações 0 Anterior
-
In Vitro Diagnostics Market Expands with Rising Focus on Early Disease DetectionExecutive Summary In Vitro Diagnostics (IVD) Market: Growth Trends and Share Breakdown The global In Vitro Diagnostics (IVD) market size was valued at USD 135.73 billion in 2025 and is expected to reach USD 200.54 billion by 2033, at a CAGR of 5.00% during the forecast period In this competitive marketplace, businesses are always in struggle to seek...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
In Vitro Diagnostics Market Strengthens with Demand for Early Disease Detection"Executive Summary In Vitro Diagnostics (IVD) Market Research: Share and Size Intelligence The global In Vitro Diagnostics (IVD) market size was valued at USD 135.73 billion in 2025 and is expected to reach USD 200.54 billion by 2033, at a CAGR of 5.00% during the forecast period In Vitro Diagnostics (IVD) Market report makes available the...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Is Advanced Blood Screening Improving Global Healthcare Safety Standards?Blood Screening Market Summary: According to the latest report published by Data Bridge Market Research, the Blood Screening Market CAGR Value A number of aspects that are kept into view while creating an outstanding Blood Screening Market report include the market type, organization size, availability on-premises, end-users’ organization type, and the availability in...0 Comentários 0 Compartilhamentos 26 Visualizações 0 Anterior
Páginas Impulsionadas
© 2026 Connect Little
Portuguese